Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Jirak

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Frontiers in Medicine|July 15, 2022
Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 PneumoniaLukas J Motloch, Peter Jirak, Diana Gareeva, et al.
Biomedicines|November 11, 2022
Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 PneumoniaLukas Fiedler, Lukas J Motloch, Peter Jirak, et al.
Journal of Clinical Laboratory Analysis|September 25, 2021
Tumor necrosis factor alpha-an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?Moritz Mirna, Mario Holnthoner, Albert Topf, et al.
Journal of Personalized Medicine|May 28, 2022
Gender-Specific Differences in the Intensive Care Treatment of COVID-19 PatientsPeter Jirak, Moritz Mirna, Vincent Van Almsick, et al.
ESC Heart Failure|December 22, 2020
Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: results from a multicentre studyPeter Jirak, Robert Larbig, Zornitsa Shomanova, et al.
Clinical Hemorheology and Microcirculation|January 23, 2023
Rational and design of the REMOTE trial: An exploratory, pilot study to analyze REtinal MicrOcirculaTion in wEightlessnessStephan Binneboessel, Maryna Masyuk, Kerstin Piayda, et al.
Circulation. Heart Failure|December 11, 2020
Skeletal Muscle Function, Structure, and Metabolism in Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection FractionTarek Bekfani, Mohamed Bekhite Elsaied, Steffen Derlien, et al.
Frontiers in Pharmacology|December 11, 2023
Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathyVera Paar, Michael Haslinger, Philipp Krombholz-Reindl, et al.
Frontiers in Pharmacology|June 16, 2023
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivorsLukas Fiedler, Lukas J Motloch, Anna-Maria Dieplinger, et al.
Frontiers in Cardiovascular Medicine|August 15, 2022
Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivorsLukas J Motloch, Peter Jirak, Moritz Mirna, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Medicine|July 15, 2022
Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 PneumoniaLukas J Motloch, Peter Jirak, Diana Gareeva, et al.
Biomedicines|November 11, 2022
Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 PneumoniaLukas Fiedler, Lukas J Motloch, Peter Jirak, et al.
Journal of Clinical Laboratory Analysis|September 25, 2021
Tumor necrosis factor alpha-an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?Moritz Mirna, Mario Holnthoner, Albert Topf, et al.
Journal of Personalized Medicine|May 28, 2022
Gender-Specific Differences in the Intensive Care Treatment of COVID-19 PatientsPeter Jirak, Moritz Mirna, Vincent Van Almsick, et al.
ESC Heart Failure|December 22, 2020
Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: results from a multicentre studyPeter Jirak, Robert Larbig, Zornitsa Shomanova, et al.
Clinical Hemorheology and Microcirculation|January 23, 2023
Rational and design of the REMOTE trial: An exploratory, pilot study to analyze REtinal MicrOcirculaTion in wEightlessnessStephan Binneboessel, Maryna Masyuk, Kerstin Piayda, et al.
Circulation. Heart Failure|December 11, 2020
Skeletal Muscle Function, Structure, and Metabolism in Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection FractionTarek Bekfani, Mohamed Bekhite Elsaied, Steffen Derlien, et al.
Frontiers in Pharmacology|December 11, 2023
Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathyVera Paar, Michael Haslinger, Philipp Krombholz-Reindl, et al.
Frontiers in Pharmacology|June 16, 2023
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivorsLukas Fiedler, Lukas J Motloch, Anna-Maria Dieplinger, et al.
Frontiers in Cardiovascular Medicine|August 15, 2022
Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivorsLukas J Motloch, Peter Jirak, Moritz Mirna, et al.
Pageof 6